Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma

University of Arizona Cancer Center, Tucson

University of California Los Angeles - Jonsson Comprehensive Cancer Center, Los Angeles

University of California San Francisco Medical Center, San Francisco

University of Colorado Cancer Center, Aurora

Emory University Hospital, Atlanta

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital Cancer Center, Boston

Virginia Piper Cancer Institute, Minneapolis

Washington University School of Medicine, St Louis

New York University Langone Medical Center, New York

Saint Luke's Cancer Center - Bethlehem, Easton

Fox Chase Cancer Center, Philadelphia

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas

Inova Fairfax Hospital, Fairfax